Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life. Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alternative therapeutic op-tions.